- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
Timing Important for COVID Vax in Patients With Blood Cancers -
GENUINE Improvements: Ublituximab Plus Ibrutinib for CLL
-
COVID-19 Vaccine Failure in Patients With Blood Cancers
-
AlertEU Panel Endorses Duvelisib for CLL and Follicular Lymphoma
-
New BTK Inhibitor Pirtobrutinib Shows Promise in CLL
-
Experts Offer Roadmap for Treating CLL During the Pandemic
-
ASH 2020Early Responders Could Halt Advanced CLL Combo Therapy
-
ASH 2020Fixed Duration Ibrutinib/Venetoclax Feasible for Some CLL/SLL
Perspective View All
Journal Articles View All
-
Pulmonary Pathology of COVID-19 Following Severe Disease
-
Cardio-Oncology: Ibrutinib Effect Reveals Insights Into AF
-
Combination Obinutuzumab, Ibrutinib, and Venetoclax in CLL
-
Acalabrutinib vs Idelalisib-R or Bendamustine-R in CLL
-
Cladribine With Concurrent or Delayed Rituximab in HCL
-
Rapid Cognitive Decline in a Patient With CLL
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education